Drug study participants needed
UT Health San Antonio researchers are seeking healthy participants between the ages of 70 and 95 for a clinical trial to study what effects Rapamycin (an FDA-approved medication) has on heart function, heart muscle stiffening and other effects on circulation. Qualified participants will receive compensation.
Learn More
|
The benefits of cancer rehabilitation
Brian Fricke, MD, director of cancer rehabilitation, shares the four phases of cancer rehabilitation and how our program helps patients prepare for treatment, maintain their independence and decrease side effects after treatment.
Watch Video
|
|
|
|
|